Alnylam Pharmaceuticals (ALNY) Free Cash Flow (2009 - 2026)
Alnylam Pharmaceuticals (ALNY) recorded Free Cash Flow of $292.04 million in Q2 2026, up 152.8% from $115.51 million a year earlier and up 500.0% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Free Cash Flow (2009 - 2026) Analysis & Trends
On a TTM basis, Alnylam Pharmaceuticals' Free Cash Flow came in at $819.87 million as of Jun 30, 2026; for FY2025, it was $465.38 million.
- Across earlier years, Free Cash Flow came in at -$42.59 million in FY2024, $41.95 million in FY2023, -$613.33 million in FY2022 and -$718.07 million in FY2021.
- Quarterly Free Cash Flow has ranged from -$189.05 million in Q1 2022 to $342.32 million in Q3 2023 over the past five years.
- On a year-over-year basis, Free Cash Flow rose in two of the last four quarters, with growth averaging 205.4%.
- Per Business Quant, the preceding three quarters came in at $48.67 million (Q1 2026), $140.26 million (Q4 2025) and $338.89 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 7.30 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 3.11 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 4.48 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 6.20 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 5.34 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 3.49 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 3.43 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 302.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 1.01 Bn |
| 10 | Alnylam Pharmaceuticals | 34.23 Bn | 22.28 Bn | 992.69 Mn | 292.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 292.04 Mn |
| Mar 31, 2026 | 48.67 Mn |
| Dec 31, 2025 | 140.26 Mn |
| Sep 30, 2025 | 338.89 Mn |
| Jun 30, 2025 | 115.51 Mn |
| Mar 31, 2025 | -129.28 Mn |
| Dec 31, 2024 | -103.76 Mn |
| Sep 30, 2024 | 39.52 Mn |
| Jun 30, 2024 | 116.14 Mn |
| Mar 31, 2024 | -94.49 Mn |
| Dec 31, 2023 | -45.10 Mn |
| Sep 30, 2023 | 342.32 Mn |
| Jun 30, 2023 | -74.91 Mn |
| Mar 31, 2023 | -180.37 Mn |
| Dec 31, 2022 | -153.61 Mn |
| Sep 30, 2022 | -131.79 Mn |
| Jun 30, 2022 | -138.87 Mn |
| Mar 31, 2022 | -189.05 Mn |
| Dec 31, 2021 | -172.03 Mn |
| Sep 30, 2021 | -160.10 Mn |
API Access
Alnylam Pharmaceuticals Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();